phan metabolites through 5-hydroxytryptamine in the synovial fluid and blood of patients with rheumatoid arthritis and those with osteoarthritis were investigated in order to know the role of serotonin in the joint diseases.
were investigated in order to know the role of serotonin in the joint diseases.
A metabolic map of tryptophan in the synovial fluid was also made. There were no significant differences in the levels of 5-hydroxytryptamine and 5-hydroxyindole acetic acid in the synovial fluid between rheumatoid arthritis and osteoarthritis, but the activity of monoamine oxidase in the synovial fluid was higher in osteoarthritis than in rheumatoid arthritis. synovial fluid; serotonin; monoamine oxidase
We reported previously on the tryptophan and its metabolites in the synovial fluid in joint diseases, and a metabolic map via kynurenine pathway was made (Knox 1953; Igari et al. 1969; Tsuchizawa 1969 ). Since then the present authors have studied the metabolic pathway from tryptophan to 5-hydroxyindole acetic acid (5-HIAA) through 5-hydroxytryptamine (5-HT-serotonin) in the synovial fluid, blood and urine of patients with joint diseases (Fig. 1) and formulated a metabolic map of tryptophan metabolism via 5-HT pathway.
MATERIALS AND METHODS
The experimental materials were the synovial fluid, blood and urine of patients who were diagnosed as rheumatoid arthritis (RA) according to the diagnostic criteria of the American Rheumatism Association and as osteoarthritis (OA) of the knee joint from clinical findings, x-ray findings and laboratory data in the Department of Orthopedic Surgery of Iwate Medical University Hospital.
The experimental methods were as follows: 
DISCUSSION
Although rheumatoid arthritis is a systemic disease, the symptoms appear mainly in the joint. Therefore, the analysis of chemical constituents in patho logical synovial fluid is important to elucidate the pathogenesis. Thus far, 5-HT metabolism has been examined in patients with rhematoid arthritis and osteoarth ritis (Herrmann 1958; Kerby and Taylor 1959) .
At present, the pathway proposed by Udenfriend et al. (1958) is generally accepted as the metabolic pathway of 5-HT in the living body. According to his view, 5-HT is derived from tryptophan which is oxidized first to 5-hydroxytrypto phan, followed by production of 5-HT by the action of decarboxylase; 5-HT is then oxidatively deaminated by monoamine oxidase (MAO) to produce biologically inactive 5-HIAA, which is excreted into urine as a final metabolite.
Although Tsuchizawa et al. (1969) reported higher values of tryptophan in the synovial fluid of the patient with rheumatoid arthritis than in the patient with osteoarthritis, no significant differences in 5-HT levels were observed between them. This fact seems to indicate that activities of the enzymes such as hydro xylase and decarboxylase in the pathway from tryptophan to 5-HT are higher in osteoarthritis than in rheumatoid arthritis. Since the turn-over rate of 5-HT was found to be higher in osteoarthritis than in rhematoid arthritis, retarded metabolism of 5-HT in rheumatoid arthritis may contribute to the appearance of symptoms such as pains in the joints. The total amount of 5-HIAA excreted in 24-hr urine and its level per ml (Haverback 1956 ) were lower in rheumatoid arthritis than in osteoarthritis and in controls. This seems to be due not only to the difference in MAO activity, which is related to the breakdown of 5-HT, between rheumatoid arthritis and osteoarthritis, but also to the effects of hepato-adrenocortical functions (Spiera 1966; Toba 1970 ).
